{"name":"Biperiden","slug":"biperiden","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Biperidene","Biperidine","Biperideno","Biperidenum","Kl 373","Akineton-","α-5-Norbornen-2-yl-α-phenyl-1-piperidinepropanol","1-(bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(piperidin-1-yl)propan-1-ol","α-bicyclo[2.2.1]hept-5-en-2-yl-α-phenyl-1-piperidinepropanol","1-{bicyclo[2.2.1]hept-5-en-2-yl}-1-phenyl-3-(piperidin-1-yl)propan-1-ol"],"brands":[],"scraped":true,"has_structure":true,"cid":2381,"classes":[{"name":"anticholinergic","href":"/class/anticholinergic"}],"families":[{"name":"phenylpropylamine","href":"/substituted/phenylpropylamine"}],"physical":[{"label":"Molecular mass","value":"311.50 g/mol","copyable":false},{"label":"Appearance","value":"Crystals","copyable":false},{"label":"Melting point","value":"114 °C","copyable":false},{"label":"Solubility","value":"25.1 mg/L","copyable":false},{"label":"Predicted LogP","value":"4.3","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>21</sub>H<sub>29</sub>NO","copyable":true},{"label":"IUPAC name","value":"1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol","copyable":true},{"label":"SMILES","value":"C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O","copyable":true},{"label":"InChI","value":"InChI=1S/C21H29NO/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2","copyable":true},{"label":"InChIKey","value":"YSXKPIUOCJLQIE-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"514-65-8","copyable":true},{"label":"UNII","value":"0FRP6G56LD","copyable":true},{"label":"PubChem CID","value":"2381","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"18–24 hours","copyable":false},{"label":"Metabolism","value":"Liver hydroxylation","copyable":false},{"label":"Excretion","value":"Kidney","copyable":false},{"label":"Routes of administration","value":"By mouth, intramuscular, intravenous","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Dog",[{"kind":"LD50","organism":"Dog","route":"oral","dose":"340 mg/kg /Biperiden"},{"kind":"LD50","organism":"Dog","route":"iv","dose":"222 mg/kg /Biperiden"}]],["Rat",[{"kind":"LD50","organism":"Rat","route":"ip","dose":"270 mg/kg /Biperiden"},{"kind":"LD50","organism":"Rat","route":"oral","dose":"750 mg/kg"}]]]}],"dosing":null,"salts":[],"esters":[],"chirality":"racemic","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N04","description":"Anti-parkinson drugs"},{"code":"N04A","description":"Anticholinergic agents"},{"code":"N04AA","description":"Tertiary amines"},{"code":"N04AA02","description":""},{"code":"N04AA02","description":"Biperiden"}],"mesh":[{"name":"Antiparkinson Agents","id":"M0001494"},{"name":"Parasympatholytics","id":"M0015923"},{"name":"Muscarinic Antagonists","id":"M0028057"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"CHRM3","mechanisms":["shared target"],"partners":15,"contraindicated":0},{"target":"CHRM2","mechanisms":["shared target"],"partners":12,"contraindicated":0},{"target":"CHRM1","mechanisms":["shared target"],"partners":11,"contraindicated":0},{"target":"CHRM4","mechanisms":["shared target"],"partners":10,"contraindicated":0},{"target":"CHRM5","mechanisms":["shared target"],"partners":10,"contraindicated":0}],"mechanism":"Parkinsonism is thought to result from an imbalance between the excitatory (cholinergic) and inhibitory (dopaminergic) systems in the corpus striatum. The mechanism of action of centrally active anticholinergic drugs such as biperiden is considered to relate to competitive antagonism of acetylcholine at cholinergic receptors in the corpus striatum, which then restores the balance.","side_effects":null,"effects":null,"usernotes":[],"erowid":[{"id":114649,"title":"Zombie Med","author":"Semo","substances":"Biperiden","published":"2020 Oct 28","rating":null},{"id":97989,"title":"Breaks My Mental Abilities","author":"MrMindplays","substances":"Biperiden","published":"2015 Oct 23","rating":null}],"reddit":[{"id":"1pmn6cu","title":"A night with Biperiden (Akineton®): spiraling down to delirium","author":"Vinaverk","score":3,"posted_on":"2025-12-14","url":"https://reddit.com/r/tripreports/comments/1pmn6cu/a_night_with_biperiden_akineton_spiraling_down_to/"}],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[3]},{"jurisdiction":"Brazil","status":"C1","act":null,"refs":[4]},{"jurisdiction":"United States","status":"Prescription only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Biperiden"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/2381"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q414914"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00810"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1101"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A3112"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=514-65-8"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0014948"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07941"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID6022680"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Biperiden"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/0FRP6G56LD"},{"source":"Erowid","url":"https://www.erowid.org/experiences/exp_search.cgi"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 2381, Biperiden. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/2381>https://pubchem.ncbi.nlm.nih.gov/compound/2381</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Biperiden. UNII: 0FRP6G56LD. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/0FRP6G56LD>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/0FRP6G56LD</a>","Therapeutic Goods (Poisons Standard— June 2025) Instrument 2025. Therapeutic Goods Administration (TGA). May 2025. <a href='https://www.legislation.gov.au/F2025L00599/asmade/2025-05-28/text/original/pdf'>https://www.legislation.gov.au/F2025L00599/asmade/2025-05-28/text/original/pdf</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 07:07:00","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 07:06:56","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"ok","fetched_at":"2026-11-20 07:06:57","note":null},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 07:06:56","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 07:06:56","note":"hmdb.ca refused automated access to HMDB0014948"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 07:06:57","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 07:06:55","note":null},{"source":"reddit","status":"ok","fetched_at":"2026-11-20 07:06:56","note":null},{"source":"sider","status":"missing","fetched_at":"2026-11-20 07:06:56","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 07:06:56","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 07:06:56","note":null}],"description":"Biperiden is a anticholinergic substance."}